PMC · DOI:10.1016/j.jdcr.2025.08.001·August 19, 2025
Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid
Kayadri Ratnarajah, Steffie Arès, Elio Kechichian, Carolina Lucena Fernandes
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Chemicals3
Diseases1
Figures1
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAutoimmune Bullous Skin Diseases · Urticaria and Related Conditions · Coagulation, Bradykinin, Polyphosphates, and Angioedema